Whalegun
Lobbying

Ballad Health's latest lobbying report covers Q2 2026, at $170K. The four quarters Q4 2025–Q3 2026 total $510K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Ballad Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$510K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Ballad Health lobbying by quarter
Ballad Health lobbying by quarter
QuarterAmountReports
Q4 2022$130K2
Q1 2023$130K2
Q2 2023$130K2
Q3 2023$130K2
Q4 2023$130K2
Q1 2024$120K3
Q2 2024$100K2
Q3 2024$100K2
Q4 2024$100K2
Q1 2025$110K2
Q2 2025$130K2
Q3 2025$140K2
Q4 2025$170K2
Q1 2026$170K2
Q2 2026$170K2
Q3 2026$00

By issue

  • Medicare and Medicaid$1M · 15 reports
  • Health issues$920K · 16 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE31 reports
  • HOUSE OF REPRESENTATIVES29 reports
  • Health & Human Services, Dept of (HHS)15 reports

Firms it paid

Firm
Frogueclark$1M15 quarters
DB3$470K10 quarters
Baker Donelson Bearman Caldwell & Berkowitz$450K6 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2Frogueclark$120K
07/17for Q2DB3$50K
04/20for Q1DB3$50K
04/20for Q1Frogueclark$120K
01/20for Q4 2025DB3$50K
01/20for Q4 2025Frogueclark$120K
25/10/20for Q3 2025DB3$50K
25/10/20for Q3 2025Frogueclark$90K
25/07/21for Q2 2025Frogueclark$80K
25/07/18for Q2 2025DB3$50K
25/04/21for Q1 2025DB3$50K
25/04/21for Q1 2025Frogueclark$60K
25/01/21for Q4 2024DB3$50K
25/01/21for Q4 2024Frogueclark$50K
25/01/21for Q4 2024Frogueclark$50K
24/10/21for Q3 2024Frogueclark$50K
24/10/21for Q3 2024DB3$50K
24/07/22for Q2 2024Frogueclark$50K
24/07/19for Q2 2024DB3$50K
24/04/22for Q1 2024Frogueclark$50K